文献速递治疗药物监测与药物基因组学抗菌药物管理特殊人群用药

从治疗药物监测到模型引导的抗菌药物精准给药

From Therapeutic Drug Monitoring to Model-Informed Precision Dosing for Antibiotics.
PubMed 文献 · Clin Pharmacol Ther · 2021-03-16

本文综述了抗菌药物临床药理学、传统治疗药物监测(TDM)与模型引导精准给药(MIPD)方法,以及TDM/MIPD在氨基糖苷类、β-内酰胺类、糖肽类和利奈唑胺中的价值证据,指出危重症患者药代动力学变异大,MIPD可提高剂量个体化灵活性但需模型验证与流程再评估,评估获益的临床试验仍稀缺。

要点

  • 危重症感染患者药代动力学变异大,常感染低敏感性细菌,需个体化给药。
  • MIPD软件可简化TDM流程、提高剂量个体化灵活性,但需充分模型验证。
  • 氨基糖苷类、β-内酰胺类、糖肽类和利奈唑胺已有精准给药推荐。

核心结论

  • TDM与MIPD是感染患者抗菌药物个体化给药的重要工具。
  • MIPD可提高剂量个体化灵活性与精准度,但需模型验证和流程再评估。
  • 评估TDM/MIPD获益的临床试验仍稀缺,但为临床实施所必需。

研究设计与样本

  • 综述总结抗菌药物临床药理学、传统TDM与MIPD方法及相关证据。

主要发现

  • 危重症患者药代动力学改变且变异大,常感染低敏感性细菌。
  • MIPD软件用于简化TDM流程的研究增多。
  • 微针传感器等微创/无创技术与MIPD软件结合有潜力革新给药方式。
  • 氨基糖苷类、β-内酰胺类、糖肽类和利奈唑胺已有精准给药推荐。

关键数值与推荐

  • 对氨基糖苷类、β-内酰胺类、糖肽类和利奈唑胺推荐采用精准给药方法。

临床怎么用

  • 对危重症感染患者可结合TDM与MIPD进行抗菌药物剂量个体化。
  • 实施MIPD前需确保模型充分验证并重新评估现有工作流程。

局限性

  • 评估TDM与MIPD临床获益的严谨临床试验仍稀缺。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Therapeutic drug monitoring (TDM) and model-informed precision dosing (MIPD) have evolved as important tools to inform rational dosing of antibiotics in individual patients with infections. In particular, critically ill patients display altered, highly variable pharmacokinetics and often suffer from infections caused by less susceptible bacteria. Consequently, TDM has been used to individualize dosing in this patient group for many years. More recently, there has been increasing research on the use of MIPD software to streamline the TDM process, which can increase the flexibility and precision of dose individualization but also requires adequate model validation and re-evaluation of existing workflows. In parallel, new minimally invasive and noninvasive technologies such as microneedle-based sensors are being developed, which-together with MIPD software-have the potential to revolutionize how patients are dosed with antibiotics. Nonetheless, carefully designed clinical trials to evaluate the benefit of TDM and MIPD approaches are still sparse, but are critically needed to justify the implementation of TDM and MIPD in clinical practice. The present review summarizes the clinical pharmacology of antibiotics, conventional TDM and MIPD approaches, and evidence of the value of TDM/MIPD for aminoglycosides, beta-lactams, glycopeptides, and linezolid, for which precision dosing approaches have been recommended.

来源:Clin Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Wicha SG, Märtson AG, Nielsen EI, et al. From Therapeutic Drug Monitoring to Model-Informed Precision Dosing for Antibiotics. Clin Pharmacol Ther. 2021. PMID: 33565627. doi:10.1002/cpt.2202

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。